What oncologists believe they said and what patients believe they heard: An analysis of phase I trial discussions

Journal of Clinical Oncology

Volumn 29, Issue 1, 2011, Pages 61-68

  Jenkins, Valerie ^a   Solis Trapala, Ivonne ^a   Langridge, Carolyn ^a   Catt, Susan ^a   Talbot, Denis C ^a   Fallowfield, Lesley J ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER CENTER; CANCER PATIENT; CANCER RESEARCH; CLINICAL PRACTICE; COMMUNICATION SKILL; CONSULTATION; DOCTOR PATIENT RELATION; FEMALE; HEALTH CARE PERSONNEL; HUMAN; INTERVENTION STUDY; LIFE ORIENTATION TEST REVISED QUESTIONNAIRE; MAJOR CLINICAL STUDY; MALE; MEDICAL SPECIALIST; MENTAL HEALTH; MULTICENTER STUDY; PATIENT CODING; PHASE 1 CLINICAL TRIAL (TOPIC); PHYSICIAN; PRIORITY JOURNAL; PROGNOSIS; QUESTIONNAIRE; SEMI STRUCTURED INTERVIEW; TRAINING; UNITED KINGDOM;

ADULT; AGED; CLINICAL TRIALS, PHASE I AS TOPIC; COMMUNICATION; FEMALE; HUMANS; INFORMED CONSENT; MALE; MEDICAL ONCOLOGY; MIDDLE AGED; PHYSICIAN-PATIENT RELATIONS; PROGNOSIS; QUESTIONNAIRES;

EID: 79951990094     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2010.30.0814     Document Type: Article

References (23)

1. Jenkins V, Fallowfield L, Solis-Trapala I, et al: Discussing randomised clinical trials of cancer therapy: Evaluation of a Cancer Research UK training programme. BMJ 330:400, 2005
2. Eisenhauer EA, O'Dwyer PJ, Christian M, et al: Phase I clinical trial design in cancer drug development. J Clin Oncol 18:684-692, 2000 (Pubitemid 30078550)
3. Cox AC, Fallowfield LJ, Jenkins VA: Communication and informed consent in phase 1 trials: A review of the literature. Support Care Cancer 14:303-309, 2006
4. Jenkins VA, Anderson JL, Fallowfield LJ: Communication and informed consent in phase 1 trials: A review of the literature from January 2005 to July 2009. Support Care Cancer 18:1115-1121, 2010
5. Tomamichel M, Sessa C, Herzig S, et al: Informed consent for phase I studies: Evaluation of quantity and quality of information provided to patients. Ann Oncol 6:363-369, 1995
6. Kass N, Taylor H, Fogarty L, et al: Purpose and benefits of early phase cancer trials: What do oncologists say? What do patients hear? J Empir Res Hum Res Ethics 3:57-68, 2008
7. Christakis NA: Death Foretold: Prophecy and Prognosis in Medical Care. Chicago, IL, The University of Chicago Press, 1999
8. Henderson GE, Easter MM, Zimmer C, et al: Therapeutic misconception in early phase gene transfer trials. Soc Sci Med 62:239-253, 2006 (Pubitemid 41728121)
9. Scheier MF, Carver CS, Bridges MW: Distinguishing optimism from neuroticism (and trait anxiety, self-mastery, and self-esteem): A reevaluation of the Life Orientation Test. J Pers Soc Psychol 67:1063-1078, 1994
10. Goldberg DP, Williams P: A User's Guide to the General Health Questionnaire. Windsor, Berkshire, United Kingdom, NFER-Nelson, 1988
11. Zeger SL, Liang KY: Longitudinal data analysis for discrete and continuous outcomes. Biometrics 42:121-130, 1986
12. Lipsitz SR, Parzen M, Fitzmaurice GM, et al: A two-stage logistic regression model for analyzing inter-rater agreement. Psychometrika 68:289-298, 2003 (Pubitemid 37072769)
13. Bangdiwala SI: The Agreement Chart. Chapel Hill, NC, University of North Carolina, Institute of Statistics Mimeo Series No. 1859, 1988
14. Bangdiwala SI, Bryan HE: Using SAS software graphical procedures for the observer agreement chart. Proceedings of SAS Users Group International 12, Dallas, TX, 1987, pp 1083-1088
15. Agrawal M, Grady C, Fairclough DL, et al: Patients' decision-making process regarding participation in phase I oncology research. J Clin Oncol 24:4479-4484, 2006 (Pubitemid 46630987)
16. Weinfurt KP: Varieties of uncertainty and the validity of informed consent. Clin Trials 5:624-625, 2008; discussion 630
17. Back AL, Anderson WG, Bunch L, et al: Communication about cancer near the end of life. Cancer 113:1897-1910, 2008 (suppl 7)
18. Miller FG, Joffe S: Benefit in phase 1 oncology trials: Therapeutic misconception or reasonable treatment option? Clin Trials 5:617-623, 2008
19. Cohen L, de Moor C, Amato RJ: The association between treatment-specific optimism and depressive symptomatology in patients enrolled in a Phase I cancer clinical trial. Cancer 91:1949-1955, 2001
20. Clayton JM, Butow PN, Arnold RM, et al: Fostering coping and nurturing hope when discussing the future with terminally ill cancer patients and their caregivers. Cancer 103:1965-1975, 2005
21. Strevel EL, Newman C, Pond GR, et al: The impact of an educational DVD on cancer patients considering participation in a phase I clinical trial. Support Care Cancer 15:829-840, 2007 (Pubitemid 47387504)
22. Kass NE, Sugarman J, Medley AM, et al: An intervention to improve cancer patients' understanding of early-phase clinical trials. IRB 31:1-10, 2009
23. Knapp P, Raynor DK, Silcock J, et al: Performance-based readability testing of participant materials for a phase I trial: TGN1412. J Med Ethics 35:573-578, 2009